Colestyramine (International)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C10AC01
CAS registry number (Chemical Abstracts Service)
0011041-12-6
Therapeutic Category
Lipid lowering agent: Bile acid sequestrant
Chemical Name
A styrene-divinylbenzene copolymer containing quaternary ammonium groups.
Foreign Names
- Colestyraminum (Latin)
- Colestyramin (German)
- Colestyramine (French)
- Colestiramina (Spanish)
Generic Names
- Colestyramine (OS: BAN, DCF, JAN)
- Cholestyramine (IS)
- Cholestyramine Resin (IS)
- Cholestyramin-Harz (IS)
- Colestyraminum (IS)
- Divistyramine (IS)
- Holestiramin (IS)
- MK 325 (IS)
- Cholestyramine Resin (PH: USP 41)
- Colestyramine (PH: BP 2018, Ph. Eur. 9)
- Colestyraminum (PH: Ph. Eur. 9)
- Colestyramine Chloride (OS: BANM)
Brand Names
- Cholestamin
Chi Sheng, Taiwan - Cholestran
Pharco, Egypt - Cholestyramine Pharmascience
Pharmascience, Hong Kong - Cholestyramine-Odan
Odan Laboratories, Canada - Cholexamin
Shinlin Sinseng, Taiwan - Cinecolex
Gramón Bagó, Uruguay - Colestiramina Pharma Arte
Pharma Arte, Paraguay - Colestyramin HEXAL
Hexal, Germany - Colestyramin-ratiopharm
ratiopharm, Germany - Colestyr-CT
AbZ-Pharma, Germany - Efensol
Lazlo, Spain - Flotac [+ Diclofenac]
Novartis, Chile - Ipocol
Lagap, Switzerland - Kolestran
Sandoz, Turkey - Lipocol-Merz
Merz Pharmaceuticals, Germany - Olestyr
Pharmascience, Canada - PMS-Cholestyramine
Pharmascience, Singapore; Pharmascience, Tunisia - Prevalite
Upsher-Smith, United States - Prolertus [+ Diclofenac]
Tecnofarma, Colombia - Quantalan
Bristol-Myers Squibb, Austria; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Portugal - Questran
Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, France; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Iceland; Bristol-Myers Squibb, Kuwait; Bristol-Myers Squibb, Lebanon; Bristol-Myers Squibb, Mexico; Bristol-Myers Squibb, Netherlands; Bristol-Myers Squibb, Norway; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb Pharmaceutical, United Kingdom; Dr. Fisher Farma, Netherlands; GlaxoSmithKline, Egypt; IFET, Greece; Sanolabor, Slovenia - Questran 44.4%
Sanofi, Japan - Questran 4g
Bristol-Myers Squibb, Luxembourg - Questran Light
Bristol-M.S., Argentina; Bristol-Myers Squibb, Brazil; Bristol-Myers Squibb Pharmaceutical, United Kingdom; Central Procurement & Supplies Unit, Malta - Questran Lite
Aspen, New Zealand; Aspen Pharmacare, Australia - Questran Loc
Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Iceland; Bristol-Myers Squibb, Norway; Bristol-Myers Squibb, Sweden - Questran-A
BModesto, Netherlands; Bristol-Myers Squibb, Netherlands; Dr. Fisher Farma, Netherlands; Eureco-Pharma, Netherlands; Euro Registratie, Netherlands - Resincol
Celsius, Uruguay - Resincolestiramina
Lab Rubio, Thailand; Laboratorios Rubio, Malta; Rubio, Spain; TTN, Thailand - Semide
Shun Sheng, Taiwan - Sequest
Novell Pharmaceutical, Indonesia - Vasosan
Felgenträger, Germany; IFET, Greece - Choles
Shyh Dar, Taiwan - Questran
Bristol-Myers Squibb, Italy
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Further information on drug naming conventions: International Nonproprietary Names.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.